Solid Biosciences (SLDB) EPS (Weighted Average and Diluted) Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -82.39% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -97.49% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 61.45% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -7.15% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1,178.57% |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | 11.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.86% |
| Dec 31, 2025 | 48.04% |
| Sep 30, 2025 | 39.24% |
| Jun 30, 2025 | 31.15% |
| Mar 31, 2025 | 7.81% |
| Dec 31, 2024 | -2.00% |
| Sep 30, 2024 | 24.76% |
| Jun 30, 2024 | 51.20% |
| Mar 31, 2024 | 58.44% |
| Dec 31, 2023 | -47.06% |
| Sep 30, 2023 | 61.25% |
| Jun 30, 2023 | 62.46% |
| Mar 31, 2023 | 54.30% |
| Dec 31, 2022 | 72.36% |
| Sep 30, 2022 | -12.92% |
| Jun 30, 2022 | -1,858.82% |
| Dec 31, 2021 | 60.13% |